|
Name |
Cadina-1(10),4-diene
|
| Molecular Formula | C15H24 | |
| IUPAC Name* |
4,7-dimethyl-1-propan-2-yl-1,2,3,5,6,8a-hexahydronaphthalene
|
|
| SMILES |
CC1=CC2C(CCC(=C2CC1)C)C(C)C
|
|
| InChI |
InChI=1S/C15H24/c1-10(2)13-8-6-12(4)14-7-5-11(3)9-15(13)14/h9-10,13,15H,5-8H2,1-4H3
|
|
| InChIKey |
FUCYIEXQVQJBKY-UHFFFAOYSA-N
|
|
| Synonyms |
Cadina-1(10),4-diene; 16729-01-4; 4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene; 1-Isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene; 4,7-dimethyl-1-propan-2-yl-1,2,3,5,6,8a-hexahydronaphthalene; delta-Amorphene; (+)-delta-amorphene; D-Amorphene; Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-; cadinene (delta-); 1(10),4-Cadinadiene; DTXSID60862005; DTXSID80274505; CHEBI:140564; FT-0701082; rel-(1R,8aS)-1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene
|
|
| CAS | 16729-01-4 | |
| PubChem CID | 10223 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 204.35 | ALogp: | 3.8 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.518 |
| Caco-2 Permeability: | -4.469 | MDCK Permeability: | 0.00001460 |
| Pgp-inhibitor: | 0.707 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.927 |
| 30% Bioavailability (F30%): | 0.456 |
| Blood-Brain-Barrier Penetration (BBB): | 0.327 | Plasma Protein Binding (PPB): | 97.30% |
| Volume Distribution (VD): | 6.869 | Fu: | 2.34% |
| CYP1A2-inhibitor: | 0.321 | CYP1A2-substrate: | 0.591 |
| CYP2C19-inhibitor: | 0.374 | CYP2C19-substrate: | 0.916 |
| CYP2C9-inhibitor: | 0.554 | CYP2C9-substrate: | 0.785 |
| CYP2D6-inhibitor: | 0.018 | CYP2D6-substrate: | 0.19 |
| CYP3A4-inhibitor: | 0.355 | CYP3A4-substrate: | 0.497 |
| Clearance (CL): | 7.421 | Half-life (T1/2): | 0.051 |
| hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.172 |
| Drug-inuced Liver Injury (DILI): | 0.741 | AMES Toxicity: | 0.018 |
| Rat Oral Acute Toxicity: | 0.062 | Maximum Recommended Daily Dose: | 0.034 |
| Skin Sensitization: | 0.037 | Carcinogencity: | 0.229 |
| Eye Corrosion: | 0.006 | Eye Irritation: | 0.203 |
| Respiratory Toxicity: | 0.021 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001072 | ![]() |
1.000 | D04CSZ | ![]() |
0.273 | ||
| ENC002227 | ![]() |
0.464 | D0P1FO | ![]() |
0.235 | ||
| ENC000800 | ![]() |
0.464 | D0O1UZ | ![]() |
0.224 | ||
| ENC000762 | ![]() |
0.458 | D04ATM | ![]() |
0.222 | ||
| ENC000763 | ![]() |
0.458 | D09PJX | ![]() |
0.207 | ||
| ENC000831 | ![]() |
0.439 | D0F2AK | ![]() |
0.200 | ||
| ENC002224 | ![]() |
0.439 | D04GJN | ![]() |
0.198 | ||
| ENC002223 | ![]() |
0.439 | D0WO8W | ![]() |
0.197 | ||
| ENC003087 | ![]() |
0.439 | D01CKY | ![]() |
0.196 | ||
| ENC002374 | ![]() |
0.414 | D0K5WS | ![]() |
0.190 | ||